Body mass index effects on risk of Ovarian cancer: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 18, 2014, Pages 7665-7671

  Poorolajal, Jalal ^a   Jenabi, Ensiyeh ^b   Masoumi, Seyyedeh Zahra ^c  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Body mass index; Menopause; Meta analysis; Ovarian neoplasms; Risk factor

Indexed keywords

BODY MASS; CASE CONTROL STUDY; COMPLICATION; FEMALE; HUMAN; IRAN; META ANALYSIS; OBESITY; OVARIAN NEOPLASMS; PHYSIOLOGY; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; RISK FACTOR;

BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; IRAN; OBESITY; OVARIAN NEOPLASMS; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; RISK FACTORS;

EID: 84908023002     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.18.7665     Document Type: Article

References (46)

1. Acmaz G, Aksoy H, Albayrak E, et al (2014). Evaluation of endometrial precancerous lesions in postmenopausal obese women-a high risk group? Asian Pac J Cancer Prev, 15, 195-8.
2. Alegre MM, Knowles M, Robison RA, et al (2013). Mechanics behind breast cancer prevention-focus on obesity, exercise and dietary fat. Asian Pac J Cancer Prev, 14, 2207-12.
3. Anderson JP, Ross JA, Folsom AR (2004). Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women's Health Study. Cancer, 100, 1515-21.
4. Bandera EV (2007). Nutritional factors in ovarian cancer prevention: What have we learned in the past 5 years? Nutr Cancer, 59, 142-51.
5. Beehler GP, Sekhon M, Baker JA, et al (2006). Risk of ovarian cancer associated with BMI varies by menopausal status. J Nutr, 136, 2881-6.
6. Begg CB, Mazumdar M (1994). Operating characteristics of a rank cor relation test for publication bias. Biometrics, 50, 1088-101.
7. Brinton LA, Lamb EJ, Moghissi KS, et al (2004). Ovarian cancer risk associated with varying causes of infertility. Fertility and Sterility, 82, 405-14.
8. Cheraghi Z, Poorolajal J, Hashem T, et al (2012). Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PloS one, 7, 51446.
9. Chionh F, Baglietto L, Krishnan K, et al (2010). Physical activity, body size and composition, and risk of ovarian cancer. Cancer Causes Control, 21, 2183-94.
10. Collaborative Group on Epidemiological Studies of Ovarian Cancer (2012). Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med, 9, 1001200.
11. Delort L, Kwiatkowski F, Chalabi N, et al (2009). Central adiposity as a major risk factor of ovarian cancer. Anticancer Res, 29, 5229-34.
12. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
13. Egger M, Davey SG, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
14. Engeland A, Tretli S, Bjørge T (2003). Height, body mass index, and ovarian cancer: A follow-up of 1.1 million Norweigian women. J Natl Cancer Inst, 95, 1244-8.
15. Gulcelik MA, Colakoglu K, Dincer H, et al (2012). Associations between adiponectin and two different cancers: breast and colon. Asian Pac J Cancer Prev, 13, 395-8.
16. Higgins JPT, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
17. Joshi RK, Lee SA (2014). Obesity related adipokines and colorectal cancer: a review and meta-analysis. Asian Pac J Cancer Prev, 15, 397-405.
18. Kaneko R, Nakazaki N, Tagawa T, et al (2014). A new index of abdominal obesity which effectively predicts risk of colon tumor development in female Japanese. Asian Pac J Cancer Prev, 15, 1005-10.
19. Kotsopoulos J, Baer HJ, Tworoger SS (2010). Anthropometric measures and risk of epithelial ovarian cancer: Results from the nurses' health study. Obesity, 18, 1625-31.
20. Kuper H, Cramer DW, Titus-Ernstoff L (2002). Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? Cancer Causes Control, 13, 455-63.
21. Lacey Jr JV, Leitzmann M, Brinton LA, et al (2006). Weight, height, and body mass index and risk for ovarian cancer in a cohort study. Ann Epidemiol, 16, 869-76.
22. Lahmann PH, Cust AE, Friedenreich CM, et al (2010). Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer, 126, 2404-15.
23. Lawlor DA, Bedford C, Taylor M, et al (2002). Agreement between measured and self reported weight in older women. Results from the British Women's Heart and Health Study. Age Ageing, 31, 169-74.
24. Leitzmann MF, Koebnick C, Danforth KN, et al (2009). Body mass index and risk of ovarian cancer. Cancer, 115, 812-22.
25. Lukanova A, Bjor O, Kaaks R, et al (2006). Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer, 118, 458-66.
26. Minatoya M, Kutomi G, Asakura S, et al (2013). Equol, adiponectin, insulin levels and risk of breast cancer. Asian Pac J Cancer Prev, 14, 2191-9.
27. Moorman PG, Palmieri RT, Akushevich L, et al (2009). Ovarian cancer risk factors in African-American and white women. Am J Epidemiol, 170, 598-606.
28. Nagle CM, Olsen CM, Webb PM, et al (2008). Endometrioid and clear cell ovarian cancers-A comparative analysis of risk factors. Eur J Cancer, 44, 2477-84.
29. Niwa Y, Yatsuya H, Tamakoshi K, et al (2005). Relationship between body mass index and the risk of ovarian cancer in the Japanese population: findings from the Japanese Collaborate Cohort (JACC) study. J Obstet Gynaecol Res, 31, 452-8.
30. Olsen CM, Green AC, Whiteman DC, et al (2007). Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer, 43, 690-709.
31. Olsen CM, Nagle CM, Whiteman DC, et al (2008). Body size and risk of epithelial ovarian and related cancers: a population-based case-control study. Int J Cancer, 123, 450-6.
32. Organization WH 2000. Obesity: preventing and managing the global epidemic, World Health Organization.
33. Permuth-Wey J, Sellers TA (2009). Epidemiology of ovarian cancer. In 'Cancer Epidemiology', Eds Springer, 413-37
34. Peterson NB, Trentham-Dietz A, Newcomb PA, et al (2006). Relation of anthropometric measurements to ovarian cancer risk in a population-based case-control study (United States). Cancer Causes Control, 17, 459-67.
35. Purdie DM, Bain CJ, Webb PM, et al (2001). Body size and ovarian cancer: case-control study and systematic review (Australia). Cancer Causes Control, 12, 855-63.
36. Riman T, Dickman PW, Nilsson S, et al (2001). Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol, 83, 575-85.
37. Sangrajrang S, Chaiwerawattana A, Ploysawang P, et al (2013). Obesity, diet and physical inactivity and risk of breast cancer in Thai women. Asian Pac J Cancer Prev, 14, 7023-7.
38. Schouten LJ, Goldbohm RA, van den Brandt PA (2003). Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol, 157, 424-33.
39. Schouten LJ, Rivera C, Hunter DJ, et al (2008). Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev, 17, 902-12.
40. Taylor AW, Grande ED, Gill TK, et al (2006). How valid are self reported height and weight? A comparison between CATI self report and clinic measurements using a large cohort study. Aust New Zealand J Public Health, 30, 238-46.
41. Weiderpass E, Sandin S, Inoue M, et al (2012). Risk factors for epithelial ovarian cancer in Japan-results from the Japan Public Health Center-based Prospective Study cohort. Int J Oncol, 40, 21-30.
42. Wells GA SB, O'Connell D, Peterson J, et al (2009). The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. PLoS Negl Trop Dis, 7, e2195.
43. Wells GA, Shea B, O'Connell D, et al 2009. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Online]. Ontario: Ottawa Hospital Research Institute.
44. Wernli KJ, Newcomb PA, Hampton JM, et al (2008). Hormone therapy and ovarian cancer: incidence and survival. Cancer Causes Control, 19, 605-13.
45. World Health Organisation 1996. Research on the Menopause in the 1990's. technical report series 866, Geneva, WHO.
46. World Health Organization 2000. International classification of disease for oncology, Geneva, WHO.